Endothelin receptor B predicts poor prognosis in epithelial ovarian cancer (EOC) and can be inhibited to increase intratumoral T cells and enhance tumor vaccine therapy

2524 Background: An inability of T cells to penetrate into tumor islets leads to a poor clinical outcome. We sought to identify tumor endothelial regulators of T cell trafficking. Methods: We used ...